SH3PXD2B and neoplasm: While cortactin, TKs4 and TKs5 showed no or ambiguous differences in protein expression when compared between different clinical-stages and histological grades, MT1-MMP immunoexpression increased according tumour progresses to more advanced stages and aggressive grades, suggesting it as a valuable prognostic marker in OSCC.